CELEX: 62012TB0345
Language: en
Date: 2012-11-16 00:00:00
Title: Case T-345/12 R: Order of the President of the General Court of 16 November 2012 — Akzo Nobel and Others v Commission (Interim relief — Competition — Publication of a decision finding an infringement of Article 81 EC — Rejection of claim for confidential treatment of information provided to the Commission pursuant to its Leniency Notice — Application for interim measures — Urgency — Prima facie case — Weighing up of interests)

12.1.2013   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 9/37
            
         Order of the President of the General Court of 16 November 2012 — Akzo Nobel and Others v Commission
   (Case T-345/12 R)
   (Interim relief - Competition - Publication of a decision finding an infringement of Article 81 EC - Rejection of claim for confidential treatment of information provided to the Commission pursuant to its Leniency Notice - Application for interim measures - Urgency - Prima facie case - Weighing up of interests)
   2013/C 9/68
   Language of the case: English
   
      Parties
   
   
      Applicants: Akzo Nobel NV (Amsterdam, Netherlands); Akzo Nobel Chemicals Holding AB (Nacka, Sweden); and Eka Chemicals AB (Bohus, Sweden) (represented by: C. Swaak and R. Wesseling, lawyers)
   
      Defendant: European Commission (represented by: C. Giolito, M. Kellerbauer and G. Meessen, acting as Agents)
   
      Re:
   
   Application for suspension of operation of Commission Decision C(2012) 3533 final of 24 May 2012 rejecting a request for confidential treatment submitted by Akzo Nobel NV, Akzo Nobel Chemicals Holding AB and Eka Chemicals AB pursuant to Article 8 of Decision 2011/695/EU of the President of the European Commission of 13 October 2011 on the function and terms of reference of the hearing officer in certain competition proceedings (Case COMP/38.620 — Hydrogen Peroxide and perborate) and application for interim measures seeking the continuation of the confidential treatment accorded to certain information relating to the applicants in respect of Commission Decision 2006/903/EC of 3 May 2006 relating to a proceeding under Article 81 [EC] and Article 53 of the EEA Agreement against Akzo Nobel, Akzo Nobel Chemicals Holding, Eka Chemicals, Degussa AG, Edison SpA, FMC Corporation, FMC Foret S.A., Kemira OYJ, L’Air Liquide SA, Chemoxal SA, Snia SpA, Caffaro Srl, Solvay SA/NV, Solvay Solexis SpA, Total SA, Elf Aquitaine SA and Arkema SA (Case COMP/F/C.38.620 — Hydrogen Peroxide and perborate) (OJ 2006 L 353, p. 54),
   
      Operative part of the order
   
   
               1.
            
            
               The operation of Decision C(2012) 3533 of the European Commission of 24 May 2012 rejecting a claim for confidential treatment made by Akzo Nobel NV, Akzo Nobel Chemicals Holding AB and Eka Chemicals AB pursuant to Article 8 of Decision 2011/695/EU of the President of the European Commission of 13 October 2011 on the function and terms of reference of the hearing officer in certain competition proceedings (Case COMP/38.620 — Hydrogen Peroxide and perborate) is suspended.
            
         
               2.
            
            
               The Commission is ordered to refrain from publishing a version of its Decision 2006/903/EC of 3 May 2006 relating to a proceeding under Article 81 [EC] and Article 53 of the EEA Agreement against Akzo Nobel, Akzo Nobel Chemicals Holding, Eka Chemicals, Degussa AG, Edison SpA, FMC Corporation, FMC Foret S.A., Kemira OYJ, L’Air Liquide SA, Chemoxal SA, Snia SpA, Caffaro Srl, Solvay SA/NV, Solvay Solexis SpA, Total SA, Elf Aquitaine SA and Arkema SA (Case COMP/F/C.38.620 — Hydrogen Peroxide and perborate), which is more complete, in relation to Akzo Nobel, Akzo Nobel Chemicals Holding and Eka Chemicals, than that published in September 2007 on the Commission’s website.
            
         
               3.
            
            
               The application for interim relief is dismissed for the remainder.
            
         
               4.
            
            
               The costs are reserved.